Tag Archives: post

Gilead, looking for cancer sales, swipes Roche pharma chief O'Day for CEO post

With Gilead’s CEO on the way out and revenues tumbling, the company needs a leader who can pump up cancer sales. And it may have found just that in the ranks of the world’s biggest cancer drugmaker. The Big Biotech has poached longtime Roche exec Daniel O’Day, who’ll take the helm at Gilead on March… Read More »